ANGLE’s (AGL) Buy Rating Reiterated at Berenberg Bank

ANGLE (LON:AGL)‘s stock had its “buy” rating restated by equities researchers at Berenberg Bank in a report issued on Wednesday,Digital Look reports. They currently have a GBX 40 ($0.50) price target on the stock. Berenberg Bank’s price objective suggests a potential upside of 162.21% from the company’s previous close.

ANGLE Stock Performance

Shares of AGL stock traded up GBX 2.01 ($0.02) on Wednesday, reaching GBX 15.26 ($0.19). The stock had a trading volume of 12,167,654 shares, compared to its average volume of 1,808,907. The company has a debt-to-equity ratio of 17.22, a quick ratio of 6.18 and a current ratio of 5.19. ANGLE has a 1 year low of GBX 7.11 ($0.09) and a 1 year high of GBX 25.13 ($0.31). The stock has a market cap of £49.20 million, a P/E ratio of -217.93 and a beta of 0.22. The company has a 50 day simple moving average of GBX 10.92 and a 200 day simple moving average of GBX 11.18.

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.